Company Filing History:
Years Active: 2008
Title: **Michaelann Shortencarier: Pioneering Ultrasonic Drug Delivery**
Introduction
Michaelann Shortencarier is an inventive mind based in Sacramento, CA, known for her innovative contributions to the field of drug delivery systems. With a focus on localized treatment methods, she has developed a unique approach that combines technology and medicine to enhance therapeutic outcomes.
Latest Patents
Shortencarier holds a patent for the "Ultrasonic Concentration of Drug Delivery Capsules," which details methods, compositions, and apparatus for the targeted delivery of compounds. Her invention employs radiation force to guide drug carriers to specific sites within the body. Additionally, she incorporates ultrasound radiation not only for directing these carriers but also for fragmenting them to release the associated compounds. This innovative technique also includes methods for imaging the treatment site, leading to improved precision in drug delivery. In certain cases, her approach allows for the local delivery of compounds without the use of carriers.
Career Highlights
Shortencarier is affiliated with the University of California, where she applies her research skills to advance medical technologies. Her dedication to innovation is evident in her work, which pushes the boundaries of traditional drug delivery methods and enhances the potential for targeted therapies.
Collaborations
Throughout her career, Shortencarier has collaborated with prominent researchers such as Paul Dayton and Katherine W. Ferrara. These partnerships highlight her commitment to interdisciplinary research and emphasize the value of teamwork in achieving groundbreaking advancements in the field of medical technologies.
Conclusion
Michaelann Shortencarier stands out as a leading innovator in drug delivery systems. Her patented methods leverage ultrasonic technology to improve localized treatment options, illustrating her impact on the biomedical field. As she continues her work at the University of California, her contributions are expected to pave the way for future advancements in drug delivery and therapeutic efficacy.